Diagnostic management of acute upper extremity thrombosis with Magnetic Resonance Direct Thrombus Imaging

Diagnostic management of acute upper extremity thrombosis with Magnetic Resonance Direct Thrombus Imaging - MRDTI of the upper extremity veins

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON36551

Enrollment

144

Registered

2011-05-26

Start date

2012-01-25

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arm thrombosis upper extremity thrombosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients with a suspected UE-DVT are eligible for inclusion. Patients are at least 18 years of age and able and willing to provide informed consent.

Exclusion criteria

Exclusion criteria: Patients are excluded if the duration of the complaints lasted more than 10 days, if they have a MRI contra-indication, if it is impossible to perform MRDTI within 48 hours. Patients with upper-limb amputation and those with a medical condition, associated illness, or co-morbid circumstances that made it unlikely that the study procedure would be completed are also excluded.

Design outcomes

Primary

Measure	Time frame
The primary study parameters are the sensitivity and specificity of MRDTI for diagnosing acute arm vein thrombosis. The sensitivity of MRDTI is determined by calculating te proportion of scans that are read as "positive for acute arm vein thrombosis" and the specificity is determined by calculating the proportion of scans that are read as "negative for acute arm vein thrombosis".	—

Countries

Netherlands

Outcome results